EDITORIAL | |
Precision medicine in chronic lymphatic leukemia: Cost-effectiveness analysis of the new targeted therapies
Javier Briones Farm Hosp. 2022;46(3):103-4 |
|
ORIGINALS | |
Vancomycin versus daptomycin for the treatment of confirmed gram-positive catheter-related bloodstream infections in oncology patients
Betel del Rosario-García, Gloria Julia Nazco-Casariego, Juan Luis Gómez-Sirvent, Rosa García-Marrero3, Dácil García-Rosado, Ana María López-Lirola, Juana María Oramas-Rodríguez. Jonathan González-García Farm Hosp. 2022;46(3):105-8 |
|
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
José Bruno Montoro-Ronsano, José Luis Poveda-Andrés, José Antonio Romero-Garrido, Blanca López-Chicheri Barrena, Vincenzo Alberto Vella Farm Hosp. 2022;46(3):109-15 |
|
The risk of treatment-induced QT interval prolongation
José Miguel Chaverri-Fernández, José Pablo Díaz-Madriz, Esteban Zavaleta-Monestel, Eugenia Cordero-García, Abigail Fallas-Mora, Rocío Escalona-Rodríguez Farm Hosp. 2022;46(3):116-20 |
|
Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain
Estela Moreno-Martínez, Javier de la Serna-Torroba, Vicente Escudero-Vilaplana, José Ángel Hernández-Rivas, Marina Sánchez-Cuervo, Raquel Sánchez-Hernández Farm Hosp. 2022;46(3):121-32 |
|
Medicines in exceptional circumstances for solid tumours: focusing on evidence, effectiveness, and toxicity profiles
Alberto Artiles-Medina, Marina Sáchez-Cuervo, Victoria Gómez-Dos Santos, Emilio J. Sanz-Álvarez, Ana Álvarez-Díaz, Francisco Javier Burgos-Revilla Farm Hosp. 2022;46(3):133-45 |
|
Use of tracking drugs for the search of intra-hospital adverse reactions: a pharmacovigilance study
Kely Corrêa Benedet Baesso, Diego Zapelini do Nascimento, Alessandra de Sá Soares, Fabiana Schuelter-Trevisol Farm Hosp. 2022;46(3):146-51 |
|
Reactogenicity of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19 in workers of a tertiary hospital
Cristina Palomo-Palomo, Dulce Guerra-Estévez, Alberto Parrado-González, Julia Estaire-Gutiérrez, Miguel Reyes-Malia, M. Mercedes Romero-Alonso Farm Hosp. 2022;46(3):152-6 |
|
Concordance between expectations and preferences of patients and evaluation criteria of the European Medicines Agency
Manuel David Gil-Sierra, María del Pilar Briceño-Casado, Ángel Jesús Arias-Arias, Santiago Martín-Rodríguez Farm Hosp. 2022;46(3):157-65 |
|
REVISIONS | |
Systematic review and meta-analysis of interleulin-6 inhibitors in reducing mortality for hospitalized patients with COVID-19
Emilio Jesús Alegre-del-Rey, Silvia Fénix-Caballero, Francisco Javier Salmerón-Navas, Manuel David Gil-Sierra, Jesús Francisco Sierra-Sánchez, Ramón L. Díaz-Alersi Rosety Farm Hosp. 2022;46(3):166-72 |
|
Patient-reported outcomes and mobile applications. A review of their impact on patients’ health outcomes
Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Álvaro Narrillos-Moraza, Cristina Villanueva-Bueno, Ana Herranz-Alonso, María Sanjurjo-Sáez Farm Hosp. 2022;46(3):173-81 |
|
Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients
Helmi Sulaiman, Jason A. Roberts, Mohd H. Abdul-Aziz Farm Hosp. 2022;46(3):182-90 |
|
SPECIAL ARTICLE | |
Evaluating board certification within international advance pharmacy practice frameworks
Brian E. Lawson, Josep M. Guiu-Segura Farm Hosp. 2022;46(3):191-8 |
|
OTHERS | |
Erratum found in «Farmacia Hospitalaria. 2021;45(3):126-34»
Eduardo Tejedor-Tejada, Pablo Nieto-Guindo, Javier Tejedor-Tejada, Estrella Martínez-Velasco, Araceli Gómez-Sánchez Farm Hosp 2022; 46(3): 202 |
|
CASOS CLÍNICOS | |
Inclusion of omalizumab in a trastuzumab desensitization protocol
Ester María Barreiro-Fernández, Manuel David Gil-Sierra, María del Pilar Briceño-Casado, Carmen Martínez-Díaz, Esmeralda Ríos-Sánchez Farm Hosp. 2022;46(3):199-201 |
|